Matches in SemOpenAlex for { <https://semopenalex.org/work/W2055361600> ?p ?o ?g. }
- W2055361600 endingPage "1480" @default.
- W2055361600 startingPage "1474" @default.
- W2055361600 abstract "Periprocedural hyperglycemia is an independent predictor of mortality in patients who underwent percutaneous coronary intervention (PCI). However, periprocedural management of blood glucose is not standardized. The effects of routinely continuing long-acting glucose-lowering medications before coronary angiography with possible PCI on periprocedural glycemic control have not been investigated. Patients with diabetes mellitus (DM; n = 172) were randomized to continue (Continue group; n = 86) or hold (Hold group; n = 86) their clinically prescribed long-acting glucose-lowering medications before the procedure. The primary end point was glucose level on procedural access. In a subset of patients (no DM group: n = 25; Continue group: n = 25; and Hold group: n = 25), selected measures of platelet activity that change acutely were assessed. Patients with DM randomized to the Continue group had lower blood glucose levels on procedural access compared with those randomized to the Hold group (117 [97 to 151] vs 134 [117 to 172] mg/dl, p = 0.002). There were two hypoglycemic events in the Continue group and none in the Hold group, and no adverse events in either group. Selected markers of platelet activity differed across the no DM, Continue, and Hold groups (leukocyte platelet aggregates: 8.1% [7.2 to 10.4], 8.7% [6.9 to 11.4], 10.9% [8.6 to 14.7], p = 0.007; monocyte platelet aggregates: 14.0% [10.3 to 16.3], 20.8% [16.2 to 27.0], 22.5% [15.2 to 35.4], p <0.001; soluble p-selectin: 51.9 ng/ml [39.7 to 74.0], 59.1 ng/ml [46.8 to 73.2], 72.2 ng/ml [58.4 to 77.4], p = 0.014). In conclusion, routinely continuing clinically prescribed long-acting glucose-lowering medications before coronary angiography with possible PCI help achieve periprocedural euglycemia, appear safe, and should be considered as a strategy for achieving periprocedural glycemic control. Periprocedural hyperglycemia is an independent predictor of mortality in patients who underwent percutaneous coronary intervention (PCI). However, periprocedural management of blood glucose is not standardized. The effects of routinely continuing long-acting glucose-lowering medications before coronary angiography with possible PCI on periprocedural glycemic control have not been investigated. Patients with diabetes mellitus (DM; n = 172) were randomized to continue (Continue group; n = 86) or hold (Hold group; n = 86) their clinically prescribed long-acting glucose-lowering medications before the procedure. The primary end point was glucose level on procedural access. In a subset of patients (no DM group: n = 25; Continue group: n = 25; and Hold group: n = 25), selected measures of platelet activity that change acutely were assessed. Patients with DM randomized to the Continue group had lower blood glucose levels on procedural access compared with those randomized to the Hold group (117 [97 to 151] vs 134 [117 to 172] mg/dl, p = 0.002). There were two hypoglycemic events in the Continue group and none in the Hold group, and no adverse events in either group. Selected markers of platelet activity differed across the no DM, Continue, and Hold groups (leukocyte platelet aggregates: 8.1% [7.2 to 10.4], 8.7% [6.9 to 11.4], 10.9% [8.6 to 14.7], p = 0.007; monocyte platelet aggregates: 14.0% [10.3 to 16.3], 20.8% [16.2 to 27.0], 22.5% [15.2 to 35.4], p <0.001; soluble p-selectin: 51.9 ng/ml [39.7 to 74.0], 59.1 ng/ml [46.8 to 73.2], 72.2 ng/ml [58.4 to 77.4], p = 0.014). In conclusion, routinely continuing clinically prescribed long-acting glucose-lowering medications before coronary angiography with possible PCI help achieve periprocedural euglycemia, appear safe, and should be considered as a strategy for achieving periprocedural glycemic control." @default.
- W2055361600 created "2016-06-24" @default.
- W2055361600 creator A5000919191 @default.
- W2055361600 creator A5011768075 @default.
- W2055361600 creator A5014072369 @default.
- W2055361600 creator A5020886020 @default.
- W2055361600 creator A5033438994 @default.
- W2055361600 creator A5048862688 @default.
- W2055361600 creator A5049958193 @default.
- W2055361600 creator A5050863307 @default.
- W2055361600 creator A5051486664 @default.
- W2055361600 creator A5053327237 @default.
- W2055361600 creator A5060418102 @default.
- W2055361600 creator A5080106253 @default.
- W2055361600 creator A5084210073 @default.
- W2055361600 date "2014-05-01" @default.
- W2055361600 modified "2023-09-23" @default.
- W2055361600 title "Periprocedural Glycemic Control in Patients With Diabetes Mellitus Undergoing Coronary Angiography With Possible Percutaneous Coronary Intervention" @default.
- W2055361600 cites W1484535674 @default.
- W2055361600 cites W1526927233 @default.
- W2055361600 cites W172609984 @default.
- W2055361600 cites W1966562996 @default.
- W2055361600 cites W1975663485 @default.
- W2055361600 cites W2001314483 @default.
- W2055361600 cites W2004706966 @default.
- W2055361600 cites W2011854883 @default.
- W2055361600 cites W2025475853 @default.
- W2055361600 cites W2047760971 @default.
- W2055361600 cites W2058217708 @default.
- W2055361600 cites W2059511850 @default.
- W2055361600 cites W2078795942 @default.
- W2055361600 cites W2080369437 @default.
- W2055361600 cites W2087393679 @default.
- W2055361600 cites W2097097037 @default.
- W2055361600 cites W2097332283 @default.
- W2055361600 cites W2102667962 @default.
- W2055361600 cites W2115285670 @default.
- W2055361600 cites W2118828771 @default.
- W2055361600 cites W2133803133 @default.
- W2055361600 cites W2139706988 @default.
- W2055361600 cites W2146901298 @default.
- W2055361600 cites W2153089743 @default.
- W2055361600 cites W2158666727 @default.
- W2055361600 cites W2160845940 @default.
- W2055361600 cites W2337454357 @default.
- W2055361600 cites W2769264260 @default.
- W2055361600 cites W85010934 @default.
- W2055361600 doi "https://doi.org/10.1016/j.amjcard.2014.01.428" @default.
- W2055361600 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4018663" @default.
- W2055361600 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24630791" @default.
- W2055361600 hasPublicationYear "2014" @default.
- W2055361600 type Work @default.
- W2055361600 sameAs 2055361600 @default.
- W2055361600 citedByCount "6" @default.
- W2055361600 countsByYear W20553616002014 @default.
- W2055361600 countsByYear W20553616002016 @default.
- W2055361600 countsByYear W20553616002017 @default.
- W2055361600 countsByYear W20553616002021 @default.
- W2055361600 countsByYear W20553616002023 @default.
- W2055361600 crossrefType "journal-article" @default.
- W2055361600 hasAuthorship W2055361600A5000919191 @default.
- W2055361600 hasAuthorship W2055361600A5011768075 @default.
- W2055361600 hasAuthorship W2055361600A5014072369 @default.
- W2055361600 hasAuthorship W2055361600A5020886020 @default.
- W2055361600 hasAuthorship W2055361600A5033438994 @default.
- W2055361600 hasAuthorship W2055361600A5048862688 @default.
- W2055361600 hasAuthorship W2055361600A5049958193 @default.
- W2055361600 hasAuthorship W2055361600A5050863307 @default.
- W2055361600 hasAuthorship W2055361600A5051486664 @default.
- W2055361600 hasAuthorship W2055361600A5053327237 @default.
- W2055361600 hasAuthorship W2055361600A5060418102 @default.
- W2055361600 hasAuthorship W2055361600A5080106253 @default.
- W2055361600 hasAuthorship W2055361600A5084210073 @default.
- W2055361600 hasBestOaLocation W20553616002 @default.
- W2055361600 hasConcept C126322002 @default.
- W2055361600 hasConcept C134018914 @default.
- W2055361600 hasConcept C164705383 @default.
- W2055361600 hasConcept C168563851 @default.
- W2055361600 hasConcept C203092338 @default.
- W2055361600 hasConcept C2779306644 @default.
- W2055361600 hasConcept C2780400711 @default.
- W2055361600 hasConcept C2780473172 @default.
- W2055361600 hasConcept C45393284 @default.
- W2055361600 hasConcept C500558357 @default.
- W2055361600 hasConcept C555293320 @default.
- W2055361600 hasConcept C71924100 @default.
- W2055361600 hasConceptScore W2055361600C126322002 @default.
- W2055361600 hasConceptScore W2055361600C134018914 @default.
- W2055361600 hasConceptScore W2055361600C164705383 @default.
- W2055361600 hasConceptScore W2055361600C168563851 @default.
- W2055361600 hasConceptScore W2055361600C203092338 @default.
- W2055361600 hasConceptScore W2055361600C2779306644 @default.
- W2055361600 hasConceptScore W2055361600C2780400711 @default.
- W2055361600 hasConceptScore W2055361600C2780473172 @default.
- W2055361600 hasConceptScore W2055361600C45393284 @default.
- W2055361600 hasConceptScore W2055361600C500558357 @default.
- W2055361600 hasConceptScore W2055361600C555293320 @default.
- W2055361600 hasConceptScore W2055361600C71924100 @default.